Timothy Urschel has extensive experience in regulatory affairs and quality assurance. Timothy is currently serving as the Senior Vice President of Regulatory Affairs and Quality Assurance at DP Clinical Inc. where they oversee the regulatory compliance and quality management. Prior to this, they worked as the Vice President of Regulatory Affairs and Quality Assurance at DP Clinical Inc. Timothy also held the role of Vice President Quality Assurance at Onconova Therapeutics. Before that, Timothy worked at Daiichi Sankyo, Inc. as the Head of Quality Assurance Operations and Planning, where they provided leadership for various quality management systems and oversaw various compliance activities. Timothy also worked at Asubio Pharma Co., Ltd., a subsidiary of Daiichi Sankyo Pharmaceuticals, Inc., as the Director of Regulatory Affairs and Quality Assurance. Additionally, they have experience as the Director of Regulatory Affairs at Celgene, where they led regulatory strategy and managed global submissions for product registrations. Early in their career, they worked at Transave Inc. as the Director of Regulatory Affairs and Quality Assurance and at EpiGenesis Pharmaceuticals as an Assistant Director of Regulatory Affairs and Quality Assurance.
Timothy Urschel -RQAP GCP has a strong educational background in the field of pharmaceutical studies. Timothy obtained an MBA-Pharmaceutical Studies from Fairleigh- Dickinson University in Madison, NJ, from 1988 to 1991. Prior to that, they completed their undergraduate studies at the University at Buffalo, earning a BS in Medicinal Chemistry from 1983 to 1987. Timothy also graduated from RL Thomas High School in 1983.
In addition to their degrees, Timothy Urschel -RQAP GCP has obtained several certifications related to quality assurance and clinical research. Timothy is a Registered Quality Assurance Professional - GCP (RQAO-GCP), accredited by the Society of Quality Assurance in November 2014. Timothy also holds an Accredited Clinical Researcher - GCP Certificate, obtained from the Accredited Clinical Researcher institute in August 2014. Furthermore, Timothy has a Certification in Pharmaceutical Quality Assurance awarded by the New Jersey Pharmaceutical Quality Control Association in May 1991.
January, 2023 - present
October, 2020